2009
Plasma predilution with addition of depleted plasma in a prothrombin time reagent improves the agreement between different prothrombin time methods
Osman A, Lindahl TL
Scand J Clin Lab Invest 69(3):395-400
2008
The quality of platelet concentrates produced by COBE Spectra and Trima Accel during storage for 7 days as assessed by in vitro methods
Tynngård N, Lindahl TL, Trinks M, Studer M, Berlin G
Transfusion Volume 48, Number 4, April 2008 , pp. 715-722(8)
2008
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
Magnus Grenegård, Karin Vretenbrant-Öberg, Martina Nylander, Stéphanie Désilets, Eva G. Lindström, Anders Larsson, Ida Ramström, Sofia Ramström, and Tomas L. Lindahl
J. Biol. Chem Vol. 283, Issue 27, 18493-18504
2008
Effects of Intercept pathogen inactivation on platelet function as analysed by free oscillation rheometry
Nahreen Tynngård, Britt Marie Johansson, Tomas Lindahl, Gösta Berlin, Mona Hansson
Transfusion & Apheresis Science 38:85-88
2008
Free oscillation rheometry detects changes in clot properties in pregnancy and thrombocytopenia
Nahreen Tynngård, Tomas L. Lindahl, Sofia Ramström, Tuulia Räf, Olof Rugarn, Gösta Berlin
Platelets 19:373-378
2008
The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days
Nahreen Tynngård, Tomas Lindahl, Marie Trinks, Monika Studer, Gösta Berlin
Transfusion 48:1669-1675
2008
The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine
Nylander M, Lindahl TL, Bengtsson T, Grenegård M
Platelets 19(5):352-8
2008
A possible ethanol-catalyzed rearrangement of vitamin K(1) detected by gas chromatography/mass spectrometry
Osman A, Hannestad U
Rapid Commun Mass Spectrom 22(23):3861-6
2007
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
Osman A, Enstrom C, Lindahl TL.
Blood Coagul Fibrinolysis 18(3):293-6
2007
Inverse relationship between the severity of gingivitis and platelet reactivity in stable angina pectoris
Jaremo P, Starkhammar C, Lundström A, Lindahl TL, Richter A.
J Thromb Haemost. 5(2):422-3.
2007
Osäkert prognostiskt värde av förhöjd trombinbildning
Lindahl TL.
Läkartidningen 104:315
2007
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
Vretenbrant K, Ramström S, Bjerke M, Lindahl TL.
Thromb Haemost. 97(3): 417-424.
2007
Inverse relationship between the severity of gingivitis and platelet reactivity in stable angina pectoris
Järemo P, Starkhammar C, Lundström A, Lindahl TL, Richter A.
J Thromb Haemost 5:422-3
2007
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
Osman M, Enstrom C, Lindahl TL
Blood Coagul Fibrinolysis 18:293-6
2007
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
Vretenbrant K, Ramström S, Bjerke M, Lindahl TL
Thrombosis and Haemostasis 97:417-24
2007
In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation
Axelsson S, Hägg S, Eriksson AC, Lindahl TL, Whiss PA
Clinical and Experimental Pharmacology and Physiology 34:775-780
2007
Surface plasmon resonance detection of blood coagulation and platelet adhesion under venous and arterial shear conditions
Hansson KM, Johansen K, Wetterö J, Klenkar G, Benesch J, Lundström I, Lindahl TL, Tengvall P
Biosens Bioelectron. Biosens Bioelectron 23:261-8
2007
Platelet PAR1 receptor density - Correlation to platelet activation response and changes in exposure after platelet activation
Ramström S, Öberg KV, Åkerström F, Enström C, Lindahl TL
Thromb Res 121(5):681-8
2007
Detection of surface bound complement at increasing serum anticoagulant concentrations
Arvidsson S, Askendal A, Lindahl TL, Tengvall P
Colloids Surf B Biointerfaces 62(2):214-9
2007
Imaging of blood plasma coagulation and its propagation at surfaces
Faxälv L, Tengvall P, Lindahl TL
J Biomed Mater Res A
2007
A genotyping method for VKORC1 1173C>T by Pyrosequencing® technology
Enstrom C, Osman A, Lindahl TL
Scand J Clin Lab Invest 68(5):427-430
2006
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
A. Osman, C. Enstrom, K. Arbring, P. Soderkvist and T. L. Lindahl
J Thromb Haemost 4(8):1723-9
2006
Characterisation of species differences in the platelet ADP and thrombin response
S. Nylander, C. Mattsson and T. L. Lindahl
Thromb Res 117(5):543-9
2006
Evaluation of platelet function, a method comparison
S. Nylander, K. Johansson, J. J. Van Giezen and T. L. Lindahl
Platelets 17(1):49-55
2006
Calibration services in the frame of accredited coagulation EQA schemes - Meeting the IVD directive
Ornemark U, Nilsson E, Nordin G, Egberg N, Lindahl TL, Hillarp A, Stigendahl L, Fagerberg I.
Accreditation and quality assurance 11:451-4
2006
Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer
Tynngård N, Lindahl T, Ramström S, Berlin G.
Platelets 17:545-54.
2005
A new high-performance liquid chromatographic method for determination of warfarin enantiomers
A. Osman, K. Arbring and T. L. Lindahl
J Chromatogr B Analyt Technol Biomed Life Sci 826(1-2):75-80
2005
Normal D-dimer concentration is a common finding in symptomatic outpatients with distal deep vein thrombosis
C. M. Jennersjo, I. H. Fagerberg, S. G. Karlander and T. L. Lindahl
Blood Coagul Fibrinolysis 16(7):517-23
2005
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
K. M. Hansson, S. Tosatti, J. Isaksson, J. Wettero, M. Textor, T. L. Lindahl and P. Tengvall
Biomaterials 26(8):861-72
2005
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination--a rebuttal
Egberg N, Fagerberg I, Hillarp A, Lindahl TL, Stigendal L.
J Thromb Haemost. 10:2370-1
2005
Clotting time analysis of citrated blood samples is strongly affected by the tube used for blood sampling
Ramström S.
Blood Coagul Fibrinolysis 16:447-452.
2004
Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation
S. Nylander, C. Mattsson, S. Ramstrom and T. L. Lindahl
Br J Pharmacol 142(8):1325-31
2004
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
T. L. Lindahl, N. Egberg, A. Hillarp, O. R. Odegaard, B. Edlund, J. Svensson, P. M. Sandset and M. Ranby
Thromb Haemost 91(6):1223-31
2004
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme
A. Hillarp, N. Egberg, G. Nordin, L. Stigendal, I. Fagerberg and T. L. Lindahl
Thromb Haemost 91(2):300-7
2004
Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure
U. Alehagen, U. Dahlstrom and T. L. Lindahl
Thromb Haemost 92(6):1250-8
2003
Clotting time by free oscillation rheometry and visual inspection and a viscoelastic description of the clotting phenomenon
M. Ranby, S. Ramstrom, P. O. Svensson and T. L. Lindahl
Scand J Clin Lab Invest 63(6):397-406
2003
Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood--different effects of collagen, TRAP and calcium ionophore A23187
S. Ramstrom, M. Ranby and T. L. Lindahl
Thromb Haemost 89(1):132-41
2003
Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry
S. Ramstrom, M. Ranby and T. L. Lindahl
Thromb Res 109(5-6):315-22
2003
The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation
S. Nylander, C. Mattsson, S. Ramstrom and T. L. Lindahl
Thromb Res 111(1-2):65-73
2003
Identification of low-density platelet populations with increased reactivity and elevated alpha-granule content
M. Milovanovic, J. Lysen, S. Ramstrom, T. L. Lindahl, A. Richter and P. Jaremo
Thromb Res 111(1-2):75-80
2003
A new flow cytometric method for measurement of von Willebrand factor activity
T. L. Lindahl, I. H. Fagerberg and A. Larsson
Scand J Clin Lab Invest 63(3):217-23
2003
A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy
C. M. Jackson, M. P. Esnouf and T. L. Lindahl
Pathophysiol Haemost Thromb 33(1):43-51
2002
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery
K. Wahlander, G. Larson, T. L. Lindahl, C. Andersson, L. Frison, D. Gustafsson, A. Bylock and B. I. Eriksson
Thromb Haemost 87(4):580-5
2002
The role of platelets in blood coagulation--effects of platelet agonists and GPIIb/IIIa inhibitors studied by free oscillation rheometry
S. Ramstrom, M. Ranby and T. L. Lindahl
Thromb Res 105(2):165-72
2002
Studies of fibrinogen binding to porcine platelets by flow cytometry: a method for studies of porcine platelet activation
A. Larsson, M. Eriksson and T. L. Lindahl
Platelets 13(3):153-7
2002
Anticoagulant therapy at four hospitals in Ostergotland--quality control using a shared computer program
S. Karlander and T. L. Lindahl
Lakartidningen 99(14):1592-4, 1597-8
2002
Individual variations of platelet inhibition after loading doses of clopidogrel
P. Jaremo, T. L. Lindahl, S. G. Fransson and A. Richter
J Intern Med 252(3):233-8
2002
Less variation in laboratory results after the introduction of INR. Differences between hospital laboratories and laboratories within primary health care are levelled out
A. Hillarp, N. Egberg, I. Fagerberg, T. L. Lindahl, G. Nordin and L. Stigendal
Lakartidningen 99(50):5068-70, 5073-4
2002
Surface plasmon resonance and free oscillation rheometry in combination: a useful approach for studies on haemostasis and interactions between whole blood and artificial surfaces
K. M. Hansson, P. Tengvall, I. Lundstrom, M. Ranby and T. L. Lindahl
Biosens Bioelectron 17(9):747-59
2002
Comparative studies with surface plasmon resonance and free oscillation rheometry on the inhibition of platelets with cytochalasin E and monoclonal antibodies towards GPIIb/IIIa
K. M. Hansson, P. Tengvall, I. Lundstrom, M. Ranby and T. L. Lindahl
Biosens Bioelectron 17(9):761-71
2002
Pharmaceutical thrombosis prevention in cardiovascular disease
M. Eriksson, K. Christensen, T. L. Lindahl and A. Larsson
Expert Opin Investig Drugs 11(4):553-63
2002
ADP activation induces bFGF binding to platelets in vitro
B. Akerblom, T. L. Lindahl and A. Larsson
Ups J Med Sci 107(3):165-71
2001
Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample
C. Mattsson, A. Menschiek-Lundin, K. Wahlander and T. L. Lindahl
Thromb Haemost 86(2):611-5
2001
Inverse relationship between platelet density and reactivity alterations at coronary angiography
P. Jaremo, T. L. Lindahl, S. G. Fransson, M. Milovanovic, E. Logander and A. Richter
Haemostasis 31(1):55-60
2000
Comparison of surface plasmon resonance and quartz crystal microbalance in the study of whole blood and plasma coagulation
T. P. Vikinge, K. M. Hansson, P. Sandstrom, B. Liedberg, T. L. Lindahl, I. Lundstrom, P. Tengvall and F. Hook
Biosens Bioelectron 15(11-12):605-13
2000
Blood plasma coagulation studied by surface plasmon resonance
T. P. Vikinge, K. M. Hansson, J. Benesch, K. Johansen, M. Ranby, T. L. Lindahl, B. Liedberg, I. Lundstom and P. Tengvall
J Biomed Opt 5(1):51-5
2000
Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function
P. A. Whiss, T. H. Lundahl, T. Bengtsson, T. L. Lindahl, E. Lunell and R. Larsson
Toxicol Appl Pharmacol 163(2):95-104
2000
The use of platelet density and volume measurements to estimate the severity of pre-eclampsia
P. Jaremo, T. L. Lindahl, C. Lennmarken and H. Forsgren
Eur J Clin Invest 30(12):1113-8
1999
Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio
A. M. van den Besselaar, L. L. Houbouyan-Reveillard, M. F. Aillaud, K. W. Denson, C. Droulle, M. Johnston, S. Kitchen, T. L. Lindahl, M. Marren, M. E. Martinuzzo, A. Tripodi and C. Vergnes
Thromb Haemost 82(5):1451-5
1999
Influence of three types of automated coagulometers on the international sensitivity index (ISI) of rabbit, human, and recombinant human tissue factor preparations--a multicenter study
A. M. van den Besselaar, L. L. Houbouyan, M. F. Aillaud, K. W. Denson, M. Johnston, S. Kitchen, T. L. Lindahl, M. Marren, M. E. Martinuzzo, C. Droulle, A. Tripodi and C. Vergnes
Thromb Haemost 81(1):66-70
1999
Laboratory diagnosis of thrombophilia by endothelial-cell-modulated coagulation
M. Ranby, K. M. Gustafsson and T. L. Lindahl
Blood Coagul Fibrinolysis 10(4):173-9
1999
Isocitrate as calcium ion activity buffer in coagulation assays
M. Ranby, T. Gojceta, K. Gustafsson, K. M. Hansson and T. L. Lindahl
Clin Chem 45(8 Pt 1):1176-80
1999
APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study
T. L. Lindahl, T. H. Lundahl, L. Nilsson and C. A. Andersson
Thromb Haemost 81(1):18-21
1999
Surface plasmon resonance (SPR) analysis of coagulation in whole blood with application in prothrombin time assay
K. M. Hansson, T. P. Vikinge, M. Ranby, P. Tengvall, I. Lundstrom, K. Johansen and T. L. Lindahl
Biosens Bioelectron 14(8-9):671-82
1998
Clinical evaluation of a diagnostic strategy for deep venous thrombosis with exclusion by low plasma levels of fibrin degradation product D-dimer
T. L. Lindahl, T. H. Lundahl, M. Ranby and S. G. Fransson
Scand J Clin Lab Invest 58(4):307-16
1996
Activated platelets and impaired platelet function in intensive care patients analyzed by flow cytometry
T. H. Lundahl, T. L. Lindahl, I. H. Fagerberg, N. Egberg, A. Bunescu and A. Larsson
Blood Coagul Fibrinolysis 7(2):218-20
1995
Stimulated Glanzmanns thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa
P. A. Holme, N. O. Solum, F. Brosstad, N. Egberg and T. L. Lindahl
Thromb Haemost 74(6):1533-40
1994
Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist
A. Larsson and T. L. Lindahl
Ups J Med Sci 99(2):121-9
1993
Chicken antibodies: taking advantage of evolution--a review
A. Larsson, R. M. Balow, T. L. Lindahl and P. O. Forsberg
Poult Sci 72(10):1807-12
1992
Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients
T. L. Lindahl, J. Lundahl, C. Netre and N. Egberg
Thromb Res 67(4):457-66
1992
Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation
T. L. Lindahl, R. Festin and A. Larsson
Thromb Haemost 68(2):221-5
1990
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator
T. L. Lindahl, P. I. Ohlsson and B. Wiman
Biochem J 265(1):109-13
1989
Stability of plasminogen activator inhibitor 1 (PAI-1)
T. L. Lindahl, O. Sigurdardottir and B. Wiman
Thromb Haemost 62(2):748-51






Webmaster Lars Faxälv
Copyright © 2007 Haemostasis.se